OFIX Q3 2022 Earnings — Orthofix Medical Inc. Revenue & Financial Results | Market Cap Arena

OFIXOrthofix Medical Inc.

$503M

Q3 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$114M+1.4% YoY

Gross Profit

$83M73.2% margin

Operating Income

-$6M-5.1% margin

Net Income

-$11M-9.4% margin

EPS (Diluted)

$-0.53

QoQ Revenue Growth

-3.5%

Cash Flow

Operating Cash Flow

-$1M

Free Cash Flow

-$7M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$450M

Total Liabilities

$116M

Stockholders' Equity

$334M

Cash & Equivalents

$52M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$114M	$112M	+1.4%
Gross Profit	$83M	$84M	-0.8%
Operating Income	-$6M	-$313,000	-1748.9%
Net Income	-$11M	-$2M	-393.6%

Revenue Segments

Global Spine

$86M43%

Bone Growth Therapies

$47M23%

Global Orthopedics

$28M14%

Spinal Implants

$26M13%

Biologics

$14M7%

Geographic Segments

Global Spine

$86M65%

Bone Growth Therapies

$47M35%